Auf dieser Seite
VIR Vir Biotechnology, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$11,17
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$4,8252-Wochen-Tief
$11,9452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.89B
P/E (TTM)
-6.0
EPS (TTM)
$-1.86
Umsatz (TTM)
$303M
Ihre Abzeichen
52W-Spanne
$5–$12
Analystenbewertung
BUY
Kursziel
$21
P/E
-6.0
ROE
-26.1%
Nettogewinnmarge
-83.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VIR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$11.17
Marktkapitalisierung (MRQ)
$1.89B
P/E (TTM)
-6.0
EPS (TTM)
$-1.86
Umsatz (TTM)
$303M
ROE (TTM)
-26.1%
52W-Spanne
$5–$12
VIR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Vir Biotechnology, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter367
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$69M2017-12-31 → 2025-12-31
EPS$-3.162019-12-31 → 2025-12-31
Freier Cashflow$-397M2019-12-31 → 2025-12-31
Nettogewinnmarge-83.0%2019-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | VIR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -6.05-Jahres-Durchschnitt ≈2.2 | ≈2.2 | · | · | |
| P/S (TTM) | 6.25-Jahres-Durchschnitt ≈9.7 | ≈9.7 | 7.4 | Unterbewertet | |
| K/B (MRQ) | 1.95-Jahres-Durchschnitt ≈1.7 | ≈1.7 | 3.8 | Unterbewertet | |
| Kurs / FCF (TTM) | -9.35-Jahres-Durchschnitt ≈-16.6 | ≈-16.6 | · | · | |
| Kurs / Cashflow (TTM) | -9.35-Jahres-Durchschnitt ≈-23.9 | ≈-23.9 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 1.95-Jahres-Durchschnitt ≈1.7 | ≈1.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VIR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -92.4%5-Jahres-Durchschnitt ≈-438.9% | ≈-438.9% | -171.9% | Spitzenklasse | |
| EBITDA-Marge (TTM) | -88.6%5-Jahres-Durchschnitt ≈-427.0% | ≈-427.0% | -171.9% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -82.9%5-Jahres-Durchschnitt ≈-395.1% | ≈-395.1% | -91.1% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -83.0%5-Jahres-Durchschnitt ≈-395.2% | ≈-395.2% | -159.6% | Spitzenklasse | |
| ROA (TTM) | -20.9%5-Jahres-Durchschnitt ≈-7.1% | ≈-7.1% | -32.2% | Im Einklang | |
| ROE (TTM) | -26.1%5-Jahres-Durchschnitt ≈-12.5% | ≈-12.5% | -58.3% | Spitzenklasse | |
| ROIC | -62.7%5-Jahres-Durchschnitt ≈-20.0% | ≈-20.0% | -62.7% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VIR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 6.05-Jahres-Durchschnitt ≈6.6 | ≈6.6 | 6.3 | Im Einklang | |
| Quick Ratio | 5.05-Jahres-Durchschnitt ≈5.9 | ≈5.9 | 5.1 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | VIR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -7.6%5-Jahres-Durchschnitt ≈253.1% | ≈253.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -65.1%5-Jahres-Durchschnitt ≈-40.1% | ≈-40.1% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -2.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | VIR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.1 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$186.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-125.6%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 4, 2026 | $0.47 | $0.34 | 39.8% |
| 31. März 2026 | $-0.85 | $-0.10 | -781.7% | |
| 31. Dezember 2025 | $-0.31 | $-0.50 | 37.6% | |
| 30. September 2025 | $-1.17 | $-0.86 | -35.7% | |
| 30. Juni 2025 | $-0.80 | $-0.73 | -9.5% | |
| 31. März 2025 | $-0.88 | $-0.84 | -4.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69M | $74M | $86M | $1.62B | $1.10B | $76M | $8M | $11M | |
| Cost of Revenue | $26.0K | $845.0K | $3M | $146M | $66M | $0 | $0 | · | |
| R&D Expense | $456M | $506M | $580M | $475M | $448M | $302M | $148M | $100M | |
| SG&A Expense | $92M | $119M | $174M | $162M | $161M | $71M | $38M | $29M | |
| Operating Expenses | $548M | $661M | $770M | $783M | $675M | $373M | $186M | $129M | |
| Operating Income | $-479M | $-587M | $-684M | $833M | $421M | $-297M | $-178M | $-119M | |
| Interest Income | $40M | $72M | $87M | $28M | · | · | $9M | $3M | |
| Other Non-op | $-409.0K | $-2M | $-9M | $4M | $-9M | $-4M | $-5M | $-212.0K | |
| Pretax Income | $-438M | $-523M | $-628M | $754M | $550M | $-299M | $-175M | $-116M | |
| Income Tax | $217.0K | $-1M | $-13M | $238M | $21M | $54.0K | $154.0K | $-480.0K | |
| Net Income | $-438M | $-522M | $-615M | $516M | $529M | $-299M | $-175M | $-116M | |
| EPS (Basic) | $-3.16 | $-3.83 | $-4.59 | $3.89 | $4.07 | $-2.51 | $-5.76 | · | |
| EPS (Diluted) | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 | $-2.51 | $-5.76 | · | |
| Shares (Basic) | 138,520,419 | 136,246,865 | 134,130,924 | 132,606,767 | 129,884,967 | 119,159,424 | 30,349,920 | · | |
| Shares (Diluted) | 138,520,419 | 136,246,865 | 134,130,924 | 134,810,908 | 133,437,126 | 119,159,424 | 30,349,920 | · | |
| EBITDA | $-468M | $-573M | $-665M | $839M | $426M | $-293M | $-175M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $232M | $223M | $242M | $849M | $348M | $437M | $109M | $48M | |
| Short-term Investments | $229M | $678M | $1.27B | $1.52B | $217M | $300M | $274M | $51M | |
| Receivables | · | · | · | $0 | $773M | $0 | · | · | |
| Prepaid Expense | $45M | $48M | $53M | $104M | $73M | $28M | $13M | $9M | |
| Other Current Assets | · | $100.0K | $8M | $26M | · | · | · | · | |
| Current Assets | $514M | $1.04B | $1.59B | $2.52B | $1.56B | $772M | $403M | $118M | |
| PP&E (Net) | $56M | $63M | $96M | $106M | $43M | $18M | $16M | $12M | |
| PP&E (Gross) | $103M | $100M | $130M | $126M | $57M | $27M | $21M | $14M | |
| Accum. Depreciation | $47M | $37M | $34M | $21M | $14M | $9M | $5M | $2M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $8M | $8M | $23M | $33M | $33M | $34M | $36M | $37M | |
| Total Assets | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $919M | $512M | $192M | |
| Accounts Payable | $10M | $5M | $6M | $6M | $7M | $5M | $6M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | $26M | $15M | |
| Current Liabilities | $93M | $120M | $175M | $511M | $341M | $99M | $59M | $40M | |
| Capital Leases | $89M | $90M | $112M | $124M | $134M | $67M | · | · | |
| Deferred Tax | · | · | · | $3M | $18M | $3M | $3M | · | |
| Other Non-current Liabilities | $22M | $15M | $16M | $11M | $3M | $4M | $4M | $2M | |
| Total Liabilities | $238M | $248M | $329M | $724M | $522M | $202M | $88M | $62M | |
| Common Stock | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $13.0K | $11.0K | $1.0K | |
| Paid-in Capital | $1.97B | $1.91B | $1.83B | $1.71B | $1.57B | $1.39B | $793M | $15M | |
| Retained Earnings | $-1.20B | $-760M | $-238M | $377M | $-139M | $-667M | $-369M | $-194M | |
| AOCI | $-2M | $-2M | $-815.0K | $-9M | $-1M | $-1M | $-601.0K | $-14.0K | |
| Stockholders' Equity | $765M | $1.15B | $1.59B | $2.08B | $1.43B | $717M | $424M | $-179M | |
| Liabilities + Equity | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $919M | $512M | $192M | |
| Shares Outstanding | 139,474,954 | 136,959,446 | 134,781,286 | 133,236,687 | 131,161,404 | 127,416,740 | 107,648,925 | 8,858,799 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $15M | $19M | $7M | $5M | $4M | $3M | $2M | |
| Stock-based Comp | $49M | $78M | $111M | $102M | $84M | $28M | $9M | $5M | |
| Deferred Tax | $304.0K | $-3M | $-1M | $-15M | $15M | $-52.0K | · | $-500.0K | |
| Amort. of Intangibles | · | · | $531.0K | $532.0K | $533.0K | $1M | $1M | $1M | |
| Restructuring | · | $35M | $14M | · | · | · | · | · | |
| Other Non-cash | $-15M | $-14M | $-293M | $1.05B | $-680M | $76M | $33M | · | |
| Operating Cash Flow | $-392M | $-446M | $-779M | $1.66B | $-48M | $-191M | $-130M | $-94M | |
| CapEx | $5M | $7M | $22M | $68M | $22M | $7M | $9M | $8M | |
| Investing Cash Flow | $310M | $499M | $165M | $-1.19B | $-141M | $-10M | $-256M | $-60M | |
| Stock Issued | · | · | · | $0 | $0 | $323M | $126M | · | |
| Net Stock Activity | · | · | · | $0 | · | $323M | $126M | · | |
| Financing Cash Flow | $4M | $4M | $7M | $35M | $100M | $529M | $449M | $25M | |
| Net Change in Cash | $-78M | $57M | $-607M | $505M | $-88M | $329M | $63M | $-130M | |
| Taxes Paid | $2M | $786.0K | $3M | $-252M | $0 | $0 | · | · | |
| Free Cash Flow | $-397M | $-454M | $-800M | $1.60B | $-69M | $-197M | $-139M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -699.2% | -791.3% | -794.0% | 51.6% | 38.4% | -388.9% | -2199.7% | · | |
| Net Margin | -638.9% | -703.4% | -713.8% | 31.9% | 48.2% | -391.1% | -2159.0% | · | |
| Pretax Margin | -638.6% | -705.0% | -728.9% | 46.7% | 50.2% | -391.0% | -2157.1% | · | |
| EBITDA Margin | -682.1% | -771.6% | -772.1% | 51.9% | 38.9% | -383.1% | -2159.0% | · | |
| ROA | -36.5% | -31.5% | -26.1% | 21.7% | 36.8% | -41.8% | -49.6% | · | |
| ROE | -51.1% | -43.7% | -37.7% | 24.4% | 45.8% | -39.1% | -244.1% | · | |
| ROIC | -62.7% | -50.9% | -42.1% | 27.4% | 28.2% | -41.4% | -42.0% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | 8.7 | 9.1 | 4.9 | 4.6 | 7.8 | 6.8 | · | |
| Quick Ratio | 5.0 | 7.5 | 8.6 | 4.6 | 3.9 | 7.4 | 6.5 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.7 | 0.8 | 0.1 | 0.0 | · | |
| Receivables Turnover | · | · | · | 4.2 | 2.8 | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.49 | $8.40 | $11.80 | $15.60 | $10.92 | $5.63 | $3.94 | · | |
| Revenue / Share | $0.49 | $0.54 | $0.64 | $11.99 | $8.21 | · | · | · | |
| Cash Flow / Share | $-2.83 | $-3.28 | $-5.81 | $12.34 | $-0.36 | · | · | · | |
| Cash / Share | $1.66 | $1.63 | $1.79 | $6.37 | $2.65 | $3.43 | $1.02 | · | |
| EPS (TTM) | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 | $-2.51 | $-5.76 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -7.6% | -13.9% | -94.7% | 47.5% | 1334.4% | · | · | · | |
| Revenue CAGR 3Y | -65.1% | -59.2% | 4.1% | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.1% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -3.3% | · | · | · | · | |
| Net Income YoY | · | · | · | -2.4% | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $69M | $74M | $86M | $1.62B | $1.10B | $76M | $8M | · | |
| Net Income TTM | $-438M | $-522M | $-615M | $516M | $529M | $-299M | $-175M | · | |
| Market Cap | $841M | $1.01B | $1.36B | $3.37B | $5.49B | $3.41B | $1.35B | · | |
| P/E | -1.9 | -1.9 | -2.2 | 6.6 | 10.6 | -10.7 | -2.2 | · | |
| P/S | 12.3 | 13.5 | 15.7 | 2.1 | 5.0 | 44.7 | 167.3 | · | |
| P/B | 1.1 | 0.9 | 0.9 | 1.6 | 3.8 | 4.8 | 3.2 | · | |
| P / Tangible Book | 1.1 | 0.9 | 0.9 | 1.7 | 4.0 | 5.1 | · | · | |
| P / Cash Flow | -2.1 | -2.3 | -1.7 | 2.0 | -115.4 | -17.9 | -10.4 | · | |
| P / FCF | -2.1 | -2.2 | -1.7 | 2.1 | -79.1 | -17.3 | -9.8 | · | |
| Earnings Yield | -52.4% | -52.2% | -45.6% | 15.1% | 9.5% | -9.4% | -45.8% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239M | $-29.0K | $64M | $240.0K | $1M | $3M | $12M | $2M | $3M | $56M | $17M | $3M | $4M | $63M | $49M | $375M | |
| Cost of Revenue | $0 | · | · | · | $11.0K | $0 | $684.0K | $50.0K | $52.0K | $59.0K | $798.0K | $38.0K | $22.0K | $2M | $6M | $22M | |
| R&D Expense | $135M | $109M | $88M | $151M | $98M | $119M | $106M | $195M | $105M | $100M | $109M | $145M | $168M | $158M | $155M | $114M | |
| SG&A Expense | $30M | $23M | $24M | $22M | $22M | $24M | $27M | $26M | $30M | $36M | $41M | $41M | $46M | $47M | $39M | $43M | |
| Operating Expenses | $165M | $132M | $112M | $174M | $120M | $143M | $130M | $234M | $162M | $136M | $156M | $189M | $219M | $206M | $200M | $180M | |
| Operating Income | $73M | $-132M | $-48M | $-173M | $-118M | $-140M | $-117M | $-231M | $-159M | $-80M | $-139M | $-187M | $-215M | $-143M | $-151M | $195M | |
| Interest Income | $9M | $7M | $8M | $9M | $11M | $12M | $14M | $18M | $19M | $21M | $21M | $22M | · | · | · | · | |
| Other Non-op | $-451.0K | $-254.0K | $-335.0K | $-228.0K | $226.0K | $-72.0K | $-506.0K | $-893.0K | $-535.0K | $-287.0K | $-1M | $882.0K | $-367.0K | $-8M | $-26M | $27M | |
| Pretax Income | $80M | $-126M | $-43M | $-163M | $-111M | $-121M | $-105M | $-214M | $-140M | $-65M | $-121M | $-167M | $-198M | $-143M | $-152M | $218M | |
| Income Tax | $179.0K | $170.0K | $-137.0K | $168.0K | $170.0K | $16.0K | $-86.0K | $177.0K | $-2M | $276.0K | $-5M | $-3M | $-3M | $-2M | $-50M | $42M | |
| Net Income | $80M | $-126M | $-43M | $-163M | $-111M | $-121M | $-105M | $-214M | $-138M | $-65M | $-116M | $-163M | $-195M | $-141M | $-102M | $175M | |
| EPS (Basic) | $0.48 | $-0.85 | $-0.31 | $-1.17 | $-0.80 | $-0.88 | $-0.77 | $-1.56 | $-1.02 | $-0.48 | $-0.86 | $-1.22 | $-1.45 | $-1.06 | $-0.78 | $1.32 | |
| EPS (Diluted) | $0.47 | $-0.85 | $-0.31 | $-1.17 | $-0.80 | $-0.88 | $-0.77 | $-1.56 | $-1.02 | $-0.48 | $-0.86 | $-1.22 | $-1.45 | $-1.06 | $-0.74 | $1.30 | |
| Shares (Basic) | 167,719,015 | 147,356,811 | · | 138,930,173 | 138,447,469 | 137,468,900 | · | 136,653,753 | 136,223,725 | 135,280,648 | · | 134,289,620 | 134,059,079 | 133,552,839 | · | 132,729,530 | |
| Shares (Diluted) | 168,879,127 | 147,356,811 | · | 138,930,173 | 138,447,469 | 137,468,900 | · | 136,653,753 | 136,223,725 | 135,280,648 | · | 134,289,620 | 134,059,079 | 133,552,839 | · | 134,963,317 | |
| EBITDA | $73M | $-129M | · | $-173M | $-118M | $-137M | · | $-231M | $-159M | $-76M | · | $-182M | $-211M | $-138M | · | $197M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $279M | $274M | $232M | $170M | $211M | $274M | $223M | $168M | $297M | $161M | $242M | $452M | $667M | $825M | $849M | $964M | |
| Short-term Investments | $250M | $196M | $229M | $328M | $388M | $517M | $678M | $741M | $850M | $985M | · | $1.23B | $1.17B | $1.41B | · | $1.36B | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $39M | $45M | $45M | $37M | $41M | $42M | $48M | $43M | $41M | $50M | · | $59M | $86M | $98M | · | $54M | |
| Other Current Assets | · | · | · | · | · | · | · | $0 | $1M | $4M | · | $5M | $13M | $18M | · | · | |
| Current Assets | $574M | $523M | $514M | $546M | $736M | $932M | $1.04B | $1.05B | $1.21B | $1.21B | · | $1.77B | $1.95B | $2.36B | · | $2.41B | |
| PP&E (Net) | $50M | $53M | $56M | $58M | $61M | $62M | $63M | $65M | $66M | $92M | · | $99M | $104M | $104M | · | $100M | |
| PP&E (Gross) | $103M | $103M | $103M | $103M | $102M | $101M | $100M | $100M | $99M | $131M | · | $129M | $130M | $130M | · | $119M | |
| Accum. Depreciation | $53M | $50M | $47M | $44M | $42M | $39M | $37M | $35M | $33M | $38M | · | $30M | $26M | $26M | · | $19M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | · | $17M | $17M | $17M | · | $17M | |
| Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $19M | $19M | $22M | · | $25M | $26M | $33M | · | $33M | |
| Total Assets | $1.21B | $1.03B | $1.00B | $1.02B | $1.19B | $1.31B | $1.40B | $1.50B | $1.67B | $1.79B | · | $2.04B | $2.24B | $2.67B | · | $2.70B | |
| Accounts Payable | $18M | $5M | $10M | $7M | $12M | $4M | $5M | $7M | $4M | $7M | · | $4M | $12M | $12M | · | $3M | |
| Current Liabilities | $95M | $74M | $93M | $75M | $105M | $137M | $120M | $117M | $96M | $94M | · | $165M | $226M | $485M | · | $308M | |
| Capital Leases | $84M | $87M | $89M | $91M | $93M | $88M | $90M | $93M | $95M | $109M | · | $114M | $118M | $121M | · | $127M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | · | $18M | |
| Other Non-current Liabilities | $19M | $19M | $22M | $13M | $13M | $15M | $15M | $14M | $14M | $14M | · | $13M | $12M | $8M | · | $7M | |
| Total Liabilities | $232M | $213M | $238M | $223M | $245M | $264M | $248M | $258M | $236M | $247M | · | $370M | $434M | $695M | · | $546M | |
| Common Stock | $17.0K | $16.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | · | $13.0K | $13.0K | $13.0K | · | $13.0K | |
| Paid-in Capital | $2.23B | $2.14B | $1.97B | $1.95B | $1.94B | $1.93B | $1.91B | $1.89B | $1.88B | $1.85B | · | $1.80B | $1.77B | $1.74B | · | $1.68B | |
| Retained Earnings | $-1.24B | $-1.32B | $-1.20B | $-1.15B | $-992M | $-881M | $-760M | $-655M | $-441M | $-303M | · | $-122M | $42M | $236M | · | $479M | |
| AOCI | $-5M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $1M | $-3M | $-2M | · | $-2M | $-3M | $-3M | · | $-12M | |
| Stockholders' Equity | $982M | $813M | $765M | $796M | $947M | $1.04B | $1.15B | $1.24B | $1.43B | $1.55B | $1.59B | $1.68B | $1.81B | $1.97B | $2.08B | $2.15B | |
| Liabilities + Equity | $1.21B | $1.03B | $1.00B | $1.02B | $1.19B | $1.31B | $1.40B | $1.50B | $1.67B | $1.79B | · | $2.04B | $2.24B | $2.67B | · | $2.70B | |
| Shares Outstanding | 169,185,671 | 161,234,058 | 139,474,954 | 139,022,594 | 138,886,274 | 138,063,698 | 136,959,446 | 136,706,350 | 136,590,097 | 135,843,560 | 134,781,286 | 134,497,886 | 134,230,494 | 133,930,957 | 133,236,687 | 133,027,358 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $5M | $4M | $5M | $6M | $2M | $2M | |
| Stock-based Comp | $12M | $12M | $11M | $11M | $12M | $14M | $16M | $17M | $22M | $24M | $28M | $27M | $31M | $25M | $25M | $25M | |
| Deferred Tax | · | · | · | · | · | · | $-3M | $57.0K | · | · | $-1M | $0 | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $133.0K | $133.0K | $133.0K | · | $133.0K | |
| Restructuring | · | · | · | · | · | · | $-4M | $13M | $26M | $-48.0K | · | · | · | · | · | · | |
| Other Non-cash | · | $-22M | · | · | · | $26M | · | · | · | $-72M | · | · | · | $-16M | · | · | |
| Operating Cash Flow | $123M | $-132M | $-26M | $-168M | $-120M | $-78M | $-88M | $-171M | $-78M | $-109M | $-108M | $-156M | $-389M | $-126M | $35M | $118M | |
| CapEx | $32.0K | $390.0K | $348.0K | $317.0K | $3M | $2M | $2M | $3M | $666.0K | $2M | $2M | $4M | $9M | $7M | $13M | $19M | |
| Investing Cash Flow | $-197M | $12M | $87M | $40M | $56M | $127M | $141M | $119M | $212M | $28M | $-105M | $-59M | $230M | $98M | $-153M | $-663M | |
| Stock Issued | · | $162M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $162M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $78M | $163M | $1M | $102.0K | $2M | $598.0K | $1M | $31.0K | $3M | $152.0K | $2M | $277.0K | $3M | $2M | $2M | $2M | |
| Net Change in Cash | $5M | $42M | $62M | $-127M | $-62M | $49M | $54M | $-53M | $137M | $-81M | $-211M | $-215M | $-156M | $-25M | $-116M | $-543M | |
| Taxes Paid | · | · | $154.0K | $5M | · | · | · | $0 | · | · | · | · | · | · | $-444M | $102M | |
| Free Cash Flow | · | $-133M | · | · | · | $-80M | · | · | · | $-111M | · | · | · | $-133M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 30.8% | 456172.4% | · | -72267.9% | -9754.3% | -4602.5% | · | -9718.7% | -5158.7% | -142.1% | · | -7075.9% | -5667.3% | -227.7% | · | 52.0% | |
| Net Margin | 33.5% | 433431.0% | · | -67975.4% | -9139.9% | -3989.6% | · | -8979.7% | -4500.1% | -115.8% | · | -6192.2% | -5129.7% | -223.9% | · | 46.8% | |
| Pretax Margin | 33.6% | 432844.8% | · | -67905.4% | -9125.9% | -3989.1% | · | -8972.3% | -4549.3% | -115.3% | · | -6314.0% | -5204.7% | -227.4% | · | 58.1% | |
| EBITDA Margin | 30.8% | 446479.3% | · | -72267.9% | -9754.3% | -4507.9% | · | -9718.7% | -5158.7% | -134.0% | · | -6905.3% | -5546.1% | -219.0% | · | 52.5% | |
| ROA | 6.7% | -10.8% | · | -13.0% | -7.8% | -7.8% | · | -12.1% | -7.1% | -2.9% | · | -6.9% | -8.0% | -5.1% | · | 9.0% | |
| ROE | 8.3% | -13.5% | · | -16.0% | -9.3% | -9.3% | · | -14.7% | -8.5% | -3.7% | · | -8.5% | -10.3% | -7.1% | · | 11.6% | |
| ROIC | 7.5% | -16.3% | · | -21.8% | -12.5% | -13.4% | · | -18.7% | -10.9% | -5.2% | · | -10.9% | -11.7% | -7.2% | · | 7.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 7.1 | · | 7.3 | 7.0 | 6.8 | · | 8.9 | 12.5 | 12.9 | · | 10.7 | 8.6 | 4.9 | · | 7.8 | |
| Quick Ratio | 5.6 | 6.4 | · | 6.6 | 5.7 | 5.8 | · | 7.8 | 11.9 | 12.2 | · | 10.2 | 8.1 | 4.6 | · | 7.5 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 8.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.81 | $5.04 | · | $5.73 | $6.82 | $7.56 | · | $9.08 | $10.50 | $11.39 | · | $12.45 | $13.49 | $14.71 | · | $16.16 | |
| Revenue / Share | $1.41 | $-0.00 | · | $0.00 | $0.01 | $0.02 | · | $0.02 | $0.02 | $0.42 | · | $0.02 | $0.03 | $0.47 | · | $2.78 | |
| Cash Flow / Share | · | $-0.90 | · | · | · | $-0.57 | · | · | · | $-0.81 | · | · | · | $-0.94 | · | · | |
| Cash / Share | $1.65 | $1.70 | · | $1.22 | $1.52 | $1.98 | · | $1.23 | $2.17 | $1.18 | · | $3.36 | $4.97 | $6.16 | · | $7.24 | |
| EPS (TTM) | $-1.86 | $-3.13 | · | $-3.62 | $-4.01 | $-4.23 | · | $-3.92 | $-3.58 | $-4.01 | · | $-4.47 | $-1.95 | $-1.08 | · | $8.57 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $303M | $65M | · | $17M | $19M | $21M | · | $79M | $79M | $80M | · | $119M | $491M | $446M | · | $2.38B | |
| Net Income TTM | $-252M | $-443M | · | $-500M | $-550M | $-578M | · | $-533M | $-483M | $-539M | · | $-601M | $-262M | $-144M | · | $1.14B | |
| Market Cap | $1.72B | $1.44B | · | $794M | $700M | $895M | · | $1.02B | $1.22B | $1.38B | · | $1.26B | $3.29B | $3.12B | · | $2.56B | |
| P/E | -5.5 | -2.9 | · | -1.6 | -1.3 | -1.5 | · | -1.9 | -2.5 | -2.5 | · | -2.1 | -12.6 | -21.5 | · | 2.2 | |
| P/S | 5.7 | 22.1 | · | 47.1 | 36.8 | 42.9 | · | 13.0 | 15.4 | 17.3 | · | 10.6 | 6.7 | 7.0 | · | 1.1 | |
| P/B | 1.8 | 1.8 | · | 1.0 | 0.7 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 0.8 | 1.8 | 1.6 | · | 1.2 | |
| P / Tangible Book | 1.8 | 1.8 | · | 1.0 | 0.8 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.9 | 1.6 | · | 1.2 | |
| P / Cash Flow | · | -10.9 | · | · | · | -11.5 | · | · | · | -12.6 | · | · | · | -24.8 | · | · | |
| Earnings Yield | -18.2% | -34.9% | · | -63.4% | -79.6% | -65.3% | · | -52.3% | -40.2% | -39.6% | · | -47.7% | -8.0% | -4.6% | · | 44.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $69M | $74M | $86M | $1.62B | $1.10B |
| Betriebsgewinnmarge % | -699.2% | -791.3% | -794.0% | 51.6% | 38.4% |
| Nettoergebnis | $-438M | $-522M | $-615M | $516M | $529M |
| Verwässerte EPS | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.5 | 8.7 | 9.1 | 4.9 | 4.6 |
| Quick Ratio | 5.0 | 7.5 | 8.6 | 4.6 | 3.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-397M | $-454M | $-800M | $1.60B | $-69M |
Institutionelle Eigentümer (13F) 255 Einreicher · $1.6B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
255
Gehaltener Wert
$1.6B
Neue Positionen
34
Geschlossene Positionen
43
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 34 (-42 vs. Vorquartal) | 43 (+16 vs. Vorquartal) | 95 (-25 vs. Vorquartal) | 76 (+35 vs. Vorquartal) | +7.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $210.711.705 | 20.678.283 | 13,43% | Aktien |
| ARCH Venture Management, LLC | $129.353.521 | 12.694.163 | 8,25% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.136.241 | 11.495.215 | 7,47% | Aktien |
| SB INVESTMENT ADVISERS (UK) LTD | $111.561.068 | 10.948.093 | 7,11% | Aktien |
| STATE STREET CORP | $101.534.699 | 9.964.151 | 6,47% | Aktien |
| GSK plc | $87.134.221 | 8.550.954 | 5,55% | Aktien |
| VANGUARD GROUP INC | $75.670.133 | 12.548.944 | 4,82% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $65.101.617 | 6.388.775 | 4,15% | Aktien |
| Point72 Asset Management, L.P. | $57.744.906 | 5.666.821 | 3,68% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $34.124.708 | 3.348.366 | 2,18% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $31.789.627 | 3.119.421 | 2,03% | Aktien |
| ADAR1 Capital Management, LLC | $25.033.539 | 2.456.677 | 1,60% | Aktien |
| GOLDMAN SACHS GROUP INC | $24.101.581 | 2.365.219 | 1,54% | Aktien |
| FMR LLC | $23.623.417 | 2.318.294 | 1,51% | Aktien |
| MORGAN STANLEY | $22.530.881 | 2.211.077 | 1,44% | Aktien |
| Nuveen, LLC | $20.206.180 | 1.982.942 | 1,29% | Aktien |
| Pictet Asset Management Holding SA | $19.904.290 | 1.953.316 | 1,27% | Aktien |
| Boxer Capital Management, LLC | $19.014.540 | 1.866.000 | 1,21% | Aktien |
| NORTHERN TRUST CORP | $14.593.762 | 1.432.165 | 0,93% | Aktien |
| Hudson Bay Capital Management LP | $13.899.160 | 1.364.000 | 0,89% | Aktien |
| GordonMD Global Investments LP | $13.792.695 | 1.353.552 | 0,88% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13.483.255 | 1.323.185 | 0,86% | Aktien |
| BANK OF AMERICA CORP /DE/ | $11.642.473 | 1.142.539 | 0,74% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $11.313.213 | 1.110.227 | 0,72% | Aktien |
| Sio Capital Management, LLC | $10.957.042 | 1.075.274 | 0,70% | Aktien |
| Savvy Advisors, Inc. | $10.604.376 | 1.040.665 | 0,68% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $10.361.844 | 1.016.864 | 0,66% | Aktien |
| Soleus Capital Management, L.P. | $10.190.000 | 1.000.000 | 0,65% | Aktien |
| CITADEL ADVISORS LLC | $10.101.724 | 991.337 | 0,64% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $8.699.050 | 853.685 | 0,55% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $8.575.466 | 841.557 | 0,55% | Aktien |
| Ensign Peak Advisors, Inc | $8.496.208 | 833.779 | 0,54% | Aktien |
| JPMORGAN CHASE & CO | $8.330.957 | 802.597 | 0,53% | Aktien |
| ALGERT GLOBAL LLC | $8.202.716 | 804.977 | 0,52% | Aktien |
| Saturn V Capital Management LP | $7.852.852 | 770.643 | 0,50% | Aktien |
| Bank of New York Mellon Corp | $7.075.671 | 694.374 | 0,45% | Aktien |
| Jones Hill Capital LP | $6.717.380 | 659.213 | 0,43% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $6.661.121 | 653.692 | 0,42% | Aktien |
| Qube Research & Technologies Ltd | $6.536.742 | 641.486 | 0,42% | Aktien |
| Candriam S.C.A. | $6.379.827 | 626.690 | 0,41% | Aktien |
| Clearstead Advisors, LLC | $6.197.906 | 608.234 | 0,40% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $6.098.079 | 593.776 | 0,39% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $5.980.490 | 586.898 | 0,38% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $5.924.626 | 581.416 | 0,38% | Aktien |
| Weiss Asset Management LP | $5.660.963 | 555.541 | 0,36% | Aktien |
| Avidity Partners Management LP | $5.291.667 | 519.300 | 0,34% | Aktien |
| Walleye Capital LLC | $5.240.218 | 514.251 | 0,33% | Aktien |
| Alta Partners Management Company, L.P. | $5.196.054 | 509.917 | 0,33% | Aktien |
| Invesco Ltd. | $4.845.804 | 475.545 | 0,31% | Aktien |
| Parkman Healthcare Partners LLC | $4.843.093 | 475.279 | 0,31% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners IX, LLC, Robert Nelsen, Keith Crandell, Clinton Bybee ×8 Einreichungen | 3. März 2026 | 8,50% | Änderung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 31 Insider · 13 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Marianne De Backer | President and CEO | 29. April 2026 J | 286.650 | 0 | 3 | $-947.163 |
| Jason O'Byrne | EVP & Chief Financial Officer | 20. März 2026 J | 2.500 | 0 | 3 | $-68.937 |
| Sung Lee | EVP & Chief Financial Officer | 27. März 2024 S | 100.492 | 0 | 0 | $0 |
| Howard Horn | CFO | 23. Februar 2023 S | 230.712 | 0 | 0 | $0 |
| Johanna Friedl-Naderer | EVP & Chief Operating Officer | 3. März 2023 S | 148.518 | 0 | 0 | $0 |
| Brent Sabatini | SVP, Chief Accounting Officer | 1. Juni 2026 S | 61.902 | 0 | 5 | $-113.079 |
| Vanina De Verneuil | EVP, General Counsel, Corp Sec | 25. Februar 2026 S | 112.982 | 0 | 5 | $-217.660 |
| Mark Eisner | EVP and Chief Medical Officer | 25. Februar 2026 S | 154.024 | 0 | 3 | $-49.513 |
| Ann M. Hanly | EVP & Chief Technology Officer | 24. Februar 2025 S | 117.901 | 0 | 0 | $0 |
| Phillip Pang | EVP & Chief Medical Officer | 22. Februar 2024 S | 250.111 | 0 | 0 | $0 |
| Steven J. Rice | Chief Administrative Officer | 1. Juni 2023 S | 106.840 | 0 | 0 | $0 |
| Herbert Virgin | EVP, Research & CSO | 9. August 2022 M | 262.500 | 0 | 0 | $0 |
| Jay Parrish | Chief Business Officer | 1. April 2021 M | 9.260 | 0 | 0 | $0 |
| Robert J More | Direktor | 11. August 2026 J | 517.917 | 0 | 0 | $0 |
| Timothy Coughlin | Direktor | 9. Juni 2026 A | 16.000 | 0 | 0 | $0 |
| Janet Napolitano | Direktor | 1. Juni 2026 S | 21.216 | 0 | 1 | $-30.240 |
| Ramy Farid | Direktor | 27. Mai 2026 A | 32.000 | 0 | 0 | $0 |
| Charles Elliott Sigal | Direktor | 27. Mai 2026 A | 39.806 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Direktor | 27. Mai 2026 A | 39.806 | 0 | 0 | $0 |
| Norbert W Bischofberger | Direktor | 27. Mai 2026 A | 21.333 | 0 | 0 | $0 |
| Vicki L Sato | Direktor | 1. Mai 2026 S | 1.078.391 | 0 | 10 | $-1.599.174 |
| Saira Ramasastry | Direktor | 30. Mai 2025 A | 22.619 | 0 | 0 | $0 |
| George A Scangos | Direktor | 24. Februar 2025 S | 698.239 | 0 | 0 | $0 |
| Robert Nelsen | Direktor | 30. Mai 2024 A | 584.148 | 0 | 0 | $0 |
| Robert J Perez | Direktor | 22. Mai 2023 A | 15.806 | 0 | 0 | $0 |
| SHARP PHILLIP A | Direktor | 22. Mai 2023 A | 121.174 | 0 | 0 | $0 |
| Dipchand Nishar | Direktor | 21. Mai 2021 A | 3.374 | 0 | 0 | $0 |
| Kristina Burow | Direktor | 21. Mai 2020 A | 1.000.000 | 0 | 0 | $0 |
| Klaus Frueh | Direktor | 16. Oktober 2019 C | 362.844 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | 10%-Eigentümer | 16. Oktober 2019 C | 2.777.777 | 0 | 0 | $0 |
| Alaska Permanent Fund Corp | 10%-Eigentümer | 16. Oktober 2019 C | 5.555.556 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 47 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IDNA · iShares Trust | 1,37% | 330.932 SH | 11. September 2026 | Täglich |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,78% | 120.859 SH | 2. Oktober 2026 | Täglich |
| BBC · ETFis Series Trust I | 0,67% | 36.099 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,29% | 168.048 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,21% | 48.466 SH | 2. Oktober 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 12.019 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,10% | 1.021.218 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,09% | 216.654 SH | 2. Oktober 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,09% | 18.546 SH | 2. Oktober 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,08% | 2.296 NS | 31. Juli 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,08% | 152.022 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 106.919 SH | 19. August 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,07% | 423.304 SH | 19. August 2026 | Täglich |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,06% | 59.262 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,04% | 3.144.068 SH | 11. September 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,04% | 2.019.005 SH | 19. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 79.032 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 707.200 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 58.849 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 535.641 NS | 31. Juli 2026 | N-PORT |
| TECB · iShares Trust | 0,03% | 13.104 SH | 11. September 2026 | Täglich |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,02% | 35.581 SH | 2. Oktober 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,02% | 3.484.960 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 352.449 SH | 19. August 2026 | Täglich |
| ISCG · iShares Trust | 0,02% | 15.668 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 55.806 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 9.191 SH | 11. September 2026 | Täglich |
| SMDX · Tidal Trust III | 0,01% | 1.987 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.398.053 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,01% | 4.496 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 372.749 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 22.418 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 10.879 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 9.821 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 39.437 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 41.614 SH | 10. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 173.654 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 45.317 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.846.948 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10.300 SH | 19. August 2026 | Täglich |
| IJR · iShares Trust | · | 7.406.345 SH | 10. September 2026 | Täglich |
| IJT · iShares Trust | · | 472.791 SH | 9. September 2026 | Täglich |
| IJS · iShares Trust | · | 635.538 SH | 8. September 2026 | Täglich |
| IWN · iShares Trust | · | 1.143.981 SH | 11. September 2026 | Täglich |
| XJR · iShares Trust | · | 16.840 SH | 31. August 2026 | Täglich |
| ISCB · iShares Trust | · | 5.053 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 13.735 SH | 11. September 2026 | Täglich |
VIR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$20.00
+79,1%
4 28,6%
Starker Kauf
9 64,3%
Kauf
1 7,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
9 Analysten · 2026-09-28Mittelwert-Ziel $20.78 +86,0%
← Unter allen Zielen
Aktueller Preis $11.17
Tief$15.00
Mittelwert$20.78
Hoch$30.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | · |
| GENB | · | · | · | · | · | · |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | · |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Warum ein Biotech-Fonds eine neue Position von 6 Millionen Dollar in Vir mit einem 99%-igen Aktienkursanstieg eröffnet hat
Nasdaq · 4 Monate, 1 Woche vor
Vir Biotechnology's Vorstandsvorsitzender verkaufte 22.000 Unternehmensaktien. Hier ist, was das für Investoren bedeutet.
Nasdaq · 4 Monate, 3 Wochen vor
Ist Vir Biotechnology, Inc. (VIR) eine gute Aktie, die man jetzt kaufen sollte?
Yahoo Finance · 5 Monate vor
Vir Biotechnology (VIR) CEO verkauft 73.000 Aktien für 664.000 US-Dollar
Nasdaq · 5 Monate, 3 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026